bhi-updated-logo-2017

BioHealth Innovation has announced the schedule for the next year’s Entrepreneur-in Residence (EIR) feedback sessions.  These 1:1 Sessions with EIRs take place at BioHealth Innovation's office in Rockville OR by videoconference.  There is no charge to participate but entrepreneurs must be working on a biohealth Start-Ups/innovation in the BioHealth Capital Region (MD, DC, VA).  The upcoming dates are:  

2019:  5/22, 7/24, 9/4, 10/9, 11/20

2020:  1/22, 2/26, 3/25, 4/22, 5/27         

Schedule your appointment online here.  For questions or more information, contact This email address is being protected from spambots. You need JavaScript enabled to view it..

nextstep-robotics-logo

NextStep Robotics Inc., an early-stage company that has developed a personalized robotic therapy to help treat foot drop in recovering stroke patients, announces the closing of its second funding round. The $600,000 round will allow NextStep to transition from prototyping and development to manufacturing and sales. Led by the Abell Foundation, a new investor, this round includes investments from previous private investors from Vancouver, Canada and new investors the Abell Foundation, University of Maryland (UM) Ventures, and Jeff and Brad Quinn of Engineered Medical Systems, Inc. (EMS), a partner company of the newly-formed LaunchPort™ Accelerator.

Susan-Hockfield-MIT-image

AS A CHILD, Susan Hockfield took apart anything she got her hands on to figure out how it worked. One time it was a watch, another time her mother’s iron. Her interest in the anatomy of the physical world grew over time: She pursued a career in neurobiology, and went on to teach at Yale University, where she eventually became provost. In 2005 she became the first female president of the Massachusetts Institute of Technology — and its first biologist-president.

copan-nist-gov-image

The U.S. government invests a significant amount of money to further research and technology innovation. In 2017, the federal government invested approximately $150 billion in R&D— about one-third at the 17 federal laboratories across the country and two-thirds at universities and private sector R&D institutions, according to government reports. This represents about one-third of all U.S. R&D spending.

cvr-unh-3434-logo

The angel investor market in 2018 experienced an increase in market participation in more companies, albeit at smaller amounts, according to the Center for Venture Research at the University of New Hampshire. Total angel investments in 2018 were $23.1 billion, a negligible decrease of 3.4% over 2017. A total of 66,110 entrepreneurial ventures received angel funding in 2018, an increase of 7.4% over 2017 investments. The number of active investors in 2018 rose to 334,565 as compared to 288,380 in 2017, a robust increase of 16%. The change in total dollars and the number of investments resulted in a deal size for 2018 that was smaller than in 2017, reflecting lower valuations. The increase in number of investments likely offsets a decline in activity by institutional investors in seed and start-up deals and the smaller deal size may have partially contributed to the increase in angel investors.

money-idea-invest-pixa

If 2017 was a banner year for biotech venture capital, 2018 blew it out of the water. Last year, private biotech companies reeled in a grand total of $16.8 billion, eclipsing 2017’s then-record $12.1 billion by 39%. And it wasn’t just the total spent that smashed records: The average per financing round increased too, and so did the proportion of enormous megarounds. 

biotech-blood-lab-rgb

Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical and complex vaccines could renew the innovation engine.